About Peripheral Vascular Devices
Peripheral vascular disease is a condition characterized by damage to or blockage in the peripheral blood vessels. This disease may result in the form of blood clots such as deep vein thrombosis, inflammation, or narrowing and blockage of the blood vessels. In case the peripheral vascular disease affects only the arteries, the condition is known as PAD. PAD is also considered one of the most serious complications in patients with diabetes. It is characterized by narrowed arteries due to the accumulation of plaques (composed of fat, cholesterol, and fibrous tissue) that results in reduced blood flow to the brain, organs, and limbs, especially the legs. PAD is known to increase the risk of stroke and heart attack by up to six times. The devices used for the treatment of peripheral vascular disease include stents, balloon catheters, CTO, atherectomy devices, venacava filters, and grafts.
Read more details at: http://www.bigmarketresearch.com/global-peripheral-vascular-devices-2015-2019-market
Analysts forecast the global peripheral vascular devices market to grow at a CAGR of 7.29% over the period 2014-2019.
Covered in this Report
The global peripheral vascular devices market is divided into six segments: peripheral vascular stents, PTA balloon catheters, aortic stent grafts, atherectomy devices, embolic protection devices, and others (synthetic surgical grafts, chronic total occlusion devices, inferior vena cava filters, and PTA guidewires).
Technavio's report, the Global Peripheral Vascular Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
• Abbott Laboratories